Switching from Tirzepatide to Retatrutide: What Researchers Should Know
Considering switching from tirzepatide to retatrutide? Compare the dual vs triple agonist mechanisms, clinical trial data, dosing protocols, and what researchers are reporting.
Considering switching from tirzepatide to retatrutide? Compare the dual vs triple agonist mechanisms, clinical trial data, dosing protocols, and what researchers are reporting.
No known interaction — and BPC-157 may even help with GLP-1 side effects. Here’s what we know.
Most peptides are used by both men and women in research. Here’s what women should know.
How long to take different peptides — GLP-1s, BPC-157, sermorelin, and more.
How to preserve muscle mass while losing weight on GLP-1 peptides like semaglutide.
The best time to take peptides depends on which one you’re using. Here’s a simple guide.
Peptide Sciences ceased operations in March 2026, shutting down its website and stopping all orders. The closure followed increased FDA enforcement against peptide suppliers.
BPC-157 is legal to purchase for research purposes in the United States. It is not FDA-approved for human use and is sold as a research chemical.
BPC-157 is a synthetic peptide derived from human gastric juice that has demonstrated tissue-healing and cytoprotective properties across hundreds of preclinical studies.
A deep-dive into five peptides investigated for cardiac protection in preclinical research: Hexarelin (GHS-R1a and CD36 dual receptor action), SS-31 (cardiolipin stabilization), BPC-157 (NO-mediated vascular protection), Cardiogen (cardiac gene regulation), and VIP (coronary vasodilation).